DuPont Mobility & Materials said it plans to invest $5 million in capital and operating resources at its plants in Germany and Switzerland to increase capacity for its...

Dago Caceres, Global Strategy Manager for Pharma Solutions at IFF, talks about the new IFF and the strategy ahead for the pharmaceutical division in particular.

DuPont is investing approximately $30 million in a new car adhesives plant in Zhangjiagang, Jiangsu province, China. Construction on the facility at the Yangtze River...

After completing the purchase of DuPont’s nutrition and biosciences unit, International Flavors & Fragrances (IFF) is looking to divest at least two of its expanded...

DuPont has agreed to sell its Clean Technologies business for $510 million to an international private equity consortium, comprising BroadPeak Global, Asia Green Fund and...

DuPont, along with Chemours, its former fluourochemicals and plastics business, and Corteva, the combined agrochemicals businesses of DuPont and Dow, have buried the...

DuPont has started a share exchange offer as part of a Reverse Morris Trust transaction that will see it merge its Nutrition & Biosciences (N&B) business into...

So far, the pharmaceutical industry — including CMOs/CDMOs — has responded well to the outbreak of the Covid-19 pandemic.